A5006481341- Acute Myocardial Infarction Research
- Cardiac Imaging and Diagnostics
- Coronary Interventions and Diagnostics
- Cardiovascular Function and Risk Factors
- Antiplatelet Therapy and Cardiovascular Diseases
- Coronary Artery Anomalies
- Cardiac Arrhythmias and Treatments
- Atrial Fibrillation Management and Outcomes
- Congenital Heart Disease Studies
- Venous Thromboembolism Diagnosis and Management
- Cardiac Valve Diseases and Treatments
- Cardiovascular Disease and Adiposity
- Vascular anomalies and interventions
- Cardiac Structural Anomalies and Repair
- Cardiac pacing and defibrillation studies
- Cardiovascular and Diving-Related Complications
- Cardiac and Coronary Surgery Techniques
- Peripheral Artery Disease Management
- Adipokines, Inflammation, and Metabolic Diseases
- Advanced MRI Techniques and Applications
- Health Systems, Economic Evaluations, Quality of Life
- Vascular Procedures and Complications
- Cardiovascular Health and Disease Prevention
- Cardiac Health and Mental Health
- Cardiac Arrest and Resuscitation
Medical University of Lodz
2015-2024
Ljubljana University Medical Centre
2017-2021
London School of Hygiene & Tropical Medicine
2021
Wojewódzki Szpital Zespolony
2015
Charité - Universitätsmedizin Berlin
2011-2014
Jagiellonian University
2011-2014
Columbia University Irving Medical Center
2011-2014
Cardiovascular Research Foundation
2011-2014
Moses H Cone Memorial Hospital
2011-2014
Icahn School of Medicine at Mount Sinai
2014
Treatment with the direct thrombin inhibitor bivalirudin, as compared heparin plus glycoprotein IIb/IIIa inhibitors, results in similar suppression of ischemia while reducing hemorrhagic complications patients stable angina and non-ST-segment elevation acute coronary syndromes who are undergoing percutaneous intervention (PCI). The safety efficacy bivalirudin high-risk unknown.We randomly assigned 3602 ST-segment myocardial infarction presented within 12 hours after onset symptoms were...
We hypothesized that percutaneous coronary intervention (PCI) preceded by early treatment with abciximab plus half-dose reteplase (combination-facilitated PCI) or alone (abciximab-facilitated would improve outcomes in patients acute ST-segment elevation myocardial infarction, as compared administered immediately before the procedure (primary PCI).In this international, double-blind, placebo-controlled study, we randomly assigned infarction who presented 6 hours less after onset of symptoms...
There is no consensus regarding the safety and efficacy of drug-eluting stents, as compared with bare-metal in patients ST-segment elevation myocardial infarction who are undergoing primary percutaneous coronary intervention (PCI).We randomly assigned, a 3:1 ratio, 3006 presenting to receive paclitaxel-eluting stents (2257 patients) or otherwise identical (749 patients). The two end points study were 12-month rates target-lesion revascularization for ischemia (analysis powered superiority)...
Concerns persist regarding the risk of stent thrombosis in setting primary percutaneous coronary intervention for ST-segment elevation myocardial infarction.The Harmonizing Outcomes With Revascularization and Stents Acute Myocardial Infarction (HORIZONS-AMI) trial included 3602 patients with infarction undergoing who were randomized to heparin plus a glycoprotein IIb/IIIa inhibitor (GPI) (n=1802) versus bivalirudin monotherapy (n=1800). implanted 3202 patients, including 2261 received...
We sought to determine whether a transradial (TR) approach compared with transfemoral (TF) was associated improved clinical outcomes in patients ST-segment elevation myocardial infarction (STEMI) undergoing primary percutaneous coronary intervention (PCI) post hoc analysis of the HORIZONS-AMI trial. There is paucity data comparing TR TF STEMI treated PCI and contemporary anticoagulant regimens.In HORIZONS-AMI, for performed 3,340 patients, either by (n=200) or (n=3,134). Endpoints included...
Left ventricular (LV) dysfunction during and after hospitalization for ST-segment elevation myocardial infarction (STEMI) is associated with increased mortality. Whether baseline LV impacts STEMI outcomes not well studied. Furthermore, whether bivalirudin paclitaxel-eluting stents (PES) are beneficial in patients unknown. We studied the impact of left ejection fraction (LVEF) on HORIZONS-AMI trial. LVEF was determined 2648 (73.5%) 3602 enrolled patients, who were divided into three groups...
Mean platelet volume (MPV) is a strong predictor of impaired angiographic reperfusion and 6-month mortality in ST-elevation myocardial infarction (MI) treated with primary percutaneous coronary intervention (PCI). No data available for other indices: distribution width (PDW) large cell ratio (P-LCR). The aim was to assess the impact 3 indices on long-term prognosis patients PCI acute MI.This prospective study enrolled 538 who underwent MI. Admission blood samples were measured MPV, PDW,...
Background— Reinfarction after primary percutaneous coronary intervention in patients with ST-segment–elevation myocardial infarction has negative consequences. Little is known about reinfarction drug-eluting stents and bivalirudin anticoagulation. We, therefore, sought to determine the incidence, predictors, implications of contemporary era. Methods Results— Outcomes were assessed 3202 undergoing stent implantation for Harmonizing RevascularIZatiON Stents Acute Myocardial Infarction...
Aims:We aimed to investigate the rapid induction of therapeutic hypothermia using ZOLL Proteus Intravascular Temperature Management System in patients with anterior ST-elevation myocardial infarction (STEMI) without cardiac arrest.Methods and results: A total 50 were randomised; 22 (88%; 95% confidence interval [CI]: 69-97%) group 23 (92%; CI: 74-99) control completed magnetic resonance imaging at four six days 30-day follow-up.Intravascular temperature coronary guidewire crossing after 20.5...
The aim of the study was to check, in clinical practice, potential for dose reduction lead eyewear and a ceiling-suspended shield used protect eye lens physicians working interventional cardiology. To this end, eyewear, factors were derived correct readings from dosimeter routinely outside glasses. Four types with attached loose thermoluminescent dosimeters EYE-D worn by two centres, two-month periods, during coronary angiography (CA), percutaneous intervention (PCI), pacemaker procedures....
Background: Despite primary PCI (PPCI), ST-elevation myocardial infarction (STEMI) can still result in large infarct size (IS).New technology with rapid intravascular cooling showed positive signals for reduction IS anterior STEMI. Aims:We investigated the effectiveness and safety of systemic hypothermia as an adjunct to PPCI conscious patients, STEMI, without cardiac arrest.Methods: Hypothermia was induced using ZOLL ® Proteus™ system.After randomisation 111 58 53 control groups, study...